Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

biological

biological is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 15
News articles 0
Drug details — biological
Class
—
Route
—
Patents
20
Programs
15
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

biological is an FDA-listed pharmaceutical active ingredient.

Key facts

INN biological

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. APHP200019 Phase 3 · PARItec · Patient with sepsis complicated by ARDS
  2. Biological/Vaccine Phase 3 · Vertex Pharmaceuticals (Australia) · Type 1 Diabetes
  3. GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations) Phase 3 · GSK Glaxo Smith · Influenza
  4. GSK Biologicals' GSK2340274A (two different formulations) Phase 2 · GSK Glaxo Smith · Influenza
  5. Radiation: Radiation Therapy；Biological: Personalized tumor peptide vaccine Phase 2 · Hospital Authority · Advanced Tumors
  6. Zelboraf 240 mg film-coated tablets Phase 2 · Ningbo Cancer Hospital · Patients with metastatic or unresectable locally advanced ma
  7. BNT351-01 Phase 1 · BioNTech SE · HIV-1 infection
  8. BP45361 Phase 1 · HOFFMANN-LA ROCHE · Parkinson’s Disease

Related patents

Browse patents

  1. US 12378258

    Biologically active molecules, conjugates thereof, and therapeutic uses

    Expires 2045-07-31T00:00:00.000Z

    granted

  2. US 12364791

    Conformal coating of biological surfaces

    Expires 2045-07-17T00:00:00.000Z

    granted

  3. US 12171864

    Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method

    Expires 2044-12-19T00:00:00.000Z

    granted

  4. US 12097306

    Conformal coating of biological surfaces

    Expires 2044-09-19T00:00:00.000Z

    granted

  5. US 12038433

    Methods and apparatus for high-throughput screening for testing permeability and retention of compounds across biological barriers

    Expires 2044-07-11T00:00:00.000Z

    granted

  6. US 12036234

    Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues

    Expires 2044-07-11T00:00:00.000Z

    granted

  7. US 11986533

    Macromonomers and bottle brush polymers for delivery of biological agents

    Expires 2044-05-16T00:00:00.000Z

    granted

  8. US 11867695

    Compositions and methods for detecting protease activity in biological systems

    Expires 2044-01-04T00:00:00.000Z

    granted

  9. US 11781101

    3D-printed models of biological microenvironments

    Expires 2043-10-05T00:00:00.000Z

    granted

  10. US 11744834

    Metal-porphyrin complexes for the inactivation of the biological activity of opioids

    Expires 2043-08-31T00:00:00.000Z

    granted

  11. US 11684585

    Nanoscale coatings for encapsulation of biological entities

    Expires 2043-06-22T00:00:00.000Z

    granted

  12. US 11564884

    Cationic block polymer micelles for delivery of biological agents

    Expires 2043-01-26T00:00:00.000Z

    granted

  13. US 11439708

    Nanotube trans-membrane channels mimicking biological porins

    Expires 2042-09-08T00:00:00.000Z

    granted

  14. US 11345715

    Biologically active molecules, conjugates thereof, and therapeutic uses

    Expires 2042-05-26T00:00:00.000Z

    granted

  15. US 11311624

    Inhibitors of MEK/PI3K, JAK/MEK, JAK/PI3K/mTOR and MEK/PI3K/mTOR biological pathways and methods for improving lymphatic uptake, bioavailability, and solubility of therapeutic compounds

    Expires 2042-04-21T00:00:00.000Z

    granted

  16. US 11035859

    Compositions and methods for detecting protease activity in biological systems

    Expires 2041-06-10T00:00:00.000Z

    granted

  17. US 10919877

    Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same

    Expires 2041-02-11T00:00:00.000Z

    granted

  18. US 10920190

    Folding biological tissue via programmed cellular contractility

    Expires 2041-02-11T00:00:00.000Z

    granted

  19. US 10869841

    Nanoscale coatings for encapsulation of biological entities

    Expires 2040-12-17T00:00:00.000Z

    granted

  20. US 10835495

    Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same

    Expires 2040-11-12T00:00:00.000Z

    granted

Frequently asked questions

What is biological?

biological is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.